Clinical Trials Logo

Gaucher Disease, Type III clinical trials

View clinical trials related to Gaucher Disease, Type III.

Filter by:
  • None
  • Page 1

NCT ID: NCT03519646 Completed - Clinical trials for Gaucher Disease, Type III

Eliglustat on Gaucher Disease Type IIIB

Start date: April 23, 2018
Phase: N/A
Study type: Interventional

Evaluation of the safety in the combination usage of Cerdelga and Cerezyme in type III Gaucher disease patients and the efficacy on soft tissue diseases.

NCT ID: NCT03240653 Recruiting - Clinical trials for Gaucher Disease, Type III

Gaucherite - A Study to Stratify Gaucher Disease

Gaucherite
Start date: January 1, 2014
Phase:
Study type: Observational

The purpose of this research is to review data already collected and to collect new data from adults and children in England with Gaucher Disease to determine clinical factors which predict severity and response to therapy of Gaucher disease especially in the areas of bone, cancer and brain conditions.